Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Boule Diagnostics ABSTU:8BD 47 Quick Ratio is 0.75 as of Mar. 2026, which is 23% below its 10-year median of 0.98. GuruFocus rates STU:8BD with a GF Score™ of 47/100 and a GF Value™ of €0.90. The stock has 2 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Boule Diagnostics AB ranks worse than 86.2% on this metric.
Boule Diagnostics AB has a quick ratio of 0.75. It indicates that the company cannot currently fully pay back its current liabilities.
The historical rank and industry rank for Boule Diagnostics AB's Quick Ratio or its related term are showing as below:
STU:8BD'
s Quick Ratio Range Over the Past 10 Years
Min: 0.69 Med: 0.98 Max: 1.97
Current: 0.75
During the past 13 years, Boule Diagnostics AB's highest Quick Ratio was 1.97. The lowest was 0.69. And the median was 0.98.
STU:8BD's Quick Ratio is ranked worse than 86.2% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 1.89
vs STU:8BD: 0.75
Boule Diagnostics AB (STU:8BD) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Boule Diagnostics AB Quick Ratio Related Terms
Boule Diagnostics AB Quick Ratio Historical Data
* Premium members only.
The historical data trend for Boule Diagnostics AB's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Boule Diagnostics AB's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Boule Diagnostics AB Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Boule Diagnostics AB's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Boule Diagnostics AB's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Boule Diagnostics AB's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Boule Diagnostics AB (STU:8BD) has a Quick Ratio of 0.75 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Boule Diagnostics AB and its competitors. This is 23% below median its historical median of 0.98. Over the past decade, Boule Diagnostics AB's Quick Ratio has ranged from 0.69 to 1.97. According to the industry distribution chart, Boule Diagnostics AB ranks #737 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 86.2%.
Is Boule Diagnostics AB's Quick Ratio too high?
Boule Diagnostics AB's current Quick Ratio of 0.75 is 23% below median its 10-year median of 0.98. Over the past 10 years, this metric has ranged from a low of 0.69 to a high of 1.97. The Medical Devices & Instruments industry median Quick Ratio is 1.89. Boule Diagnostics AB's value of 0.75 is 60.3% below this industry median. Based on the distribution chart, Boule Diagnostics AB ranks #737 out of 855 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Boule Diagnostics AB has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Boule Diagnostics AB's Quick Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Boule Diagnostics AB ranks #737 out of 855 companies for Quick Ratio. This places Boule Diagnostics AB in the lower half of its industry. The industry median Quick Ratio is 1.89. Boule Diagnostics AB's value of 0.75 is 60.3% below this benchmark. Historically, Boule Diagnostics AB's own Quick Ratio has ranged from 0.69 to 1.97 over the past decade. While the company's 10-year median is 0.98 vs. the industry median of 1.89, Boule Diagnostics AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.89, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Boule Diagnostics AB's current Quick Ratio of 0.75 is 60.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Boule Diagnostics AB and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Boule Diagnostics AB's current Quick Ratio is 0.75, which is 23% below median its own 10-year median of 0.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Boule Diagnostics AB stock overvalued right now?
Boule Diagnostics AB (STU:8BD) has a current Quick Ratio of 0.75. The stock's GF Value™ is €0.90, compared to a current price of €0.48 — trading 46.7% below its estimated fair value. The current Quick Ratio is 0.75, which is 23% below median its 10-year median of 0.98 and 60.3% below the Medical Devices & Instruments industry median of 1.89. Boule Diagnostics AB's overall GF Score™ is 47/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Boule Diagnostics AB (STU:8BD), the current Quick Ratio is 0.75 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Boule Diagnostics AB (STU:8BD) Overvalued in 2026?
Based on GuruFocus' analysis, Boule Diagnostics AB stock appears to be undervalued.
The current stock price of €0.48 is trading 46.7% below its estimated GF Value™ of €0.90.
Key valuation signals for STU:8BD:
Quick Ratio: 0.75 (23% below median its 10-year median of 0.98)
GF Value™: €0.90 vs. price of €0.48 (46.7% below fair value)
Industry Position: 60.3% below the Medical Devices & Instruments median (#737 of 855)
No single metric tells the full story. See the STU:8BD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Boule Diagnostics AB is a company operating in the diagnostics market. It is engaged in the development, manufacturing and marketing instruments and consumables for blood diagnostics. The systems are intended for small and medium-sized hospitals, clinics and laboratories within outpatient care. the company operating through two complementary business segments: Diagnostics and OEM CDS. Through its subsidiaries, the company operates in USA ,Asia, Eastern Europe, Latin America Western Europe and Africa / Middle East. The majority revenue is generated from Asia.
47GF Score
Get the complete analysis for STU:8BD
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:8BD has been successfully added to your 
